Article
Expanding the spectrum of genetic causes of DNA-specific exonuclease TREX1 variants in thrombotic microangiopathy.
Kidney international - 1 Aug 2025
Song Zhuo-Ran, Liu Zhi-Ying, Li Meng-Shi, Li Yang, Li Jing-Yi, Lv Ji-Cheng, Zhang Hong, Zhou Xu-Jie
Abstract excerpt
INTRODUCTION: Thrombotic microangiopathy (TMA) is a complex condition involving endothelial damage and microvascular thrombi. The International Society of Nephrology's aHUS International Forum identified genetic variants as crucial for tailored therapies like plasma exchange and anti-complement therapy. Recent studies suggested that new pathogenic genes beyond complement and coagulation pathways contribute to TMA...
Read the complete abstract on PubMedTopics
- Humans
- Exodeoxyribonucleases
- Phosphoproteins
- Thrombotic Microangiopathies
- Retrospective Studies
- Male
